Arkayli Biopharma, Inc. logo

Arkayli Biopharma, Inc. jobs and careers

Madison, United States

About Arkayli Biopharma, Inc.

Our mission is to develop novel medications with precision drug delivery systems to enhance efficacy and maximize safety of treatments for children and adults with vascular anomalies. Our lead product candidate, ARK001, has the potential to be the first FDA-approved non-systemic topical (applied to the skin) treatment for infantile hemangioma (IH). ARK001 has the potential to change the approach to care for IH, allowing pediatricians and dermatologists to treat before the IH requires systemic therapy.

Employees
1 to 10
Headquarters
Madison

Leadership

The top of Arkayli Biopharma, Inc.'s org chart, with how many people report into each leader.

SRPhoto of Seth Reno

Seth Reno

President and CEO

2 reports

BDPhoto of Beth A. Drolet

Beth A. Drolet

MD | Co-founder & Clinical Lead

KMPhoto of Katie MacFarlane

Katie MacFarlane

Chief Executive Officer and Executive Director